GLP-1s drive 20% of prescription spending at large self-funded plans
McKinsey Insights ·Allison Bell ·11 June 2026
About 6% of the plan participants were using the weight-loss drugs. The post GLP-1s drive 20% of prescription spending at large self-funded plans appeared first on HR Executive.
Original story
Read the full article on McKinsey Insights
We publish our own summary for informational purposes. The rights to the original content belong to its publisher.
Was this useful?

